Furthermore, the statistical analysis of the clinical data together with the immunohistochemical expression of RBMS3 showed a significantly increased expression of RBMS3 in the cancer cells of the HER2 positive cases (Mann–Whitney test p < 0.05, Figure 1b). Here, ERBB2 is linked to cancer.